Company Overview of Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc., a biotechnology company, engages in the development and commercialization of drugs/therapeutics for the treatment of dermatological disorders. Its products include EXC 001, an antisense medicine for reducing fibrosis, the amelioration of skin scarring, and other fibrotic disorders/diseases. Excaliard Pharmaceuticals was founded in 2006 and is based in Carlsbad, California. As of November 30, 2011, Excaliard Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.
2141 Palomar Airport Road
Carlsbad, CA 92011
Founded in 2006
Key Executives for Excaliard Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Excaliard Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.